No photo of Christopher Ryan

View Scopus Profile

Christopher Ryan

Professor

  • 4823 Citations
  • 37 h-Index
19982020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Christopher Ryan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 22 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Shutter-Speed Model DCE-MRI for Assessment of Response to Cancer Therapy

Huang, W. & Ryan, C.

National Institutes of Health

9/1/11 → 8/31/16

Project: Research project

    • Research Output

    A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors

    Patel, S. P., Othus, M., Chae, Y. K., Giles, F. J., Hansel, D. E., Singh, P. P., Fontaine, A., Shah, M. H., Kasi, A., Baghdadi, T. A., Matrana, M., Gatalica, Z., Korn, W. M., Hayward, J., McLeod, C., Chen, H. X., Sharon, E., Mayerson, E., Ryan, C. W., Plets, M. & 2 others, Blanke, C. D. & Kurzrock, R., May 15 2020, In : Clinical cancer research : an official journal of the American Association for Cancer Research. 26, 10, p. 2290-2296 7 p.

    Research output: Contribution to journal › Article

    Open Access
    • 4 Scopus citations

    Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

    Patel, S., von Mehren, M., Reed, D. R., Kaiser, P., Charlson, J., Ryan, C. W., Rushing, D., Livingston, M., Singh, A., Seth, R., Forscher, C., D'Amato, G., Chawla, S. P., McCarthy, S., Wang, G., Parekh, T., Knoblauch, R., Hensley, M. L., Maki, R. G. & Demetri, G. D., Aug 1 2019, In : Cancer. 125, 15, p. 2610-2620 11 p.

    Research output: Contribution to journal › Article

    Open Access
    • 5 Scopus citations

    Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial

    Tap, W. D., Gelderblom, H., Palmerini, E., Desai, J., Bauer, S., Blay, J. Y., Alcindor, T., Ganjoo, K., Martín-Broto, J., Ryan, C., Thomas, D. M., Peterfy, C., Healey, J. H., van de Sande, M., Gelhorn, H. L., Shuster, D. E., Wang, Q., Yver, A., Hsu, H. H., Lin, P. S. & 3 others, Tong-Starksen, S., Stacchiotti, S. & Wagner, A. J., Aug 10 2019, In : The Lancet. 394, 10197, p. 478-487 10 p.

    Research output: Contribution to journal › Article

    • 17 Scopus citations

    Randomized double-blind phase II study of regorafenib in patients with metastatic osteosarcoma

    Davis, L. E., Bolejack, V., Ryan, C. W., Ganjoo, K. N., Loggers, E. T., Chawla, S., Agulnik, M., Livingston, M. B., Reed, D., Keedy, V., Rushing, D., Okuno, S., Reinke, D. K., Riedel, R. F., Attia, S., Mascarenhas, L. & Maki, R. G., Jan 1 2019, In : Journal of Clinical Oncology. 37, 16, p. 1424-1431 8 p.

    Research output: Contribution to journal › Article

    • 17 Scopus citations

    Adjuvant Vascular Endothelial Growth Factor–targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis

    Sun, M., Marconi, L., Eisen, T., Escudier, B., Giles, R. H., Haas, N. B., Harshman, L. C., Quinn, D. I., Larkin, J., Pal, S. K., Powles, T., Ryan, C., Sternberg, C. N., Uzzo, R., Choueiri, T. K. & Bex, A., Jan 1 2018, (Accepted/In press) In : European Urology.

    Research output: Contribution to journal › Article

    • 27 Scopus citations